Hospital acquired Disease Testing – Hospital or Mortuary
Hospital acquired disease or nosocomial infection is a localized or systemic condition in patients occurred due to adverse reaction caused by infectious toxin agents under medical care and were absent at the time of admission. Hospitals acquired infections results in prolonged hospital stay, antimicrobial resistance, long-term disabilities, and increase mortality rate. Pathogens responsible for nosocomial infections include viruses, fungal parasites, and bacteria.
Hospital acquired infection is emerging as a major burden for society, patients, and healthcare management
Hospital acquired disease could be catheter-related blood stream infection, surgical site infection, ventilator-associated pneumonia, and catheter-associated urinary tract infection. These infection occurring in emerging economies globally. According Asia Pacific Journal of Tropical Medicine, 2017, Nosocomial infections account for around 10% in emerging economies and around 7% in developed economies out of all the infections. According to the World Health Organization (WHO), 2011, approximately around 15% patients hospitalized suffer from above mentioned infections, due to exposure to pathogens through different sources, such as healthcare staff and infected patients. Newborns, especially in emerging economies are also at high risk to develop hospital acquired infection. According to WHO, 2011, the infection rate in newborns is 20 times higher in emerging economies as compared to high income economies.
Hospital acquired infection is emerging as a major burden for society, patients, and healthcare management. Nosocomial infections could be prevented by practicing infection control programs and adopting antimicrobial control policies. For instance, National Health & Medical Research Council Australia (NHMRC), 2002 provided critical guidelines for the management of infections, prevention, and control in healthcare organizations.
The global hospital acquired disease testing market was valued at US$ 539 million in 2016 and is expected to witness a robust CAGR of 19.70% over the forecast period (2017 - 2025).
Global Hospital Acquired Disease Testing Market, by Region, 2016 (US$ Mn)
Antibodies resistance and extended hospitalization is expected to propel the growth of hospital acquired disease testing in near future
The most common nosocomial infections across the globe are the surgical wounds, urinary tract infections, and lower respiratory tract infections. The highest prevalence of these infections occurs in intensive care units, orthopedic, and acute surgical ward. Out of the mentioned infections, the urinary tract infections is the most common in the patients dwelling with urinary catheter, due to urethra is located close to the anus, which increases the changes of invasions of bacteria from large intestine into the urinary tracts. Due to these infections, the costs and the antibiotic resistance increases with extended hospitalization, which in turn expected to propel the growth of hospital acquired disease testing market. The popular techniques used for preventions, diagnosis, and testing of hospital acquired diseases are microarray, PCR, and solid phase hybridization.
North America and Europe are expected to dominate the hospital acquired disease testing market owing to encouraging government initiatives, regulatory guidelines and reimbursement scenario. Medicare and private insurance companies are eliminating the reimbursement rate due to high rate of hospital acquired infection (HAI) incidence during 2014 and 2015, adding economic pressures on hospitals to reduce hospital acquired diseases. Ion the other hand, unhygienic conditions and practices in developing and underdeveloped economies is resulting in higher incidences of HAI in these regions. Thus, generating a need for HAI testing in this regions during the forecast period.
The key market players are Diatherix laboratories, Life technologies, Cantel Medical Corporation Meridian Biosciences, Qiagen GmbH, Nordion, Roche, and Cepheid & others.
Hospital-acquired diseases are those infections that are acquired by the patient under medical care. The most common type of hospital-acquired infections are urinary tract infection, bloodstream infections, MRSA, pneumococcal infections, and gastrointestinal illnesses. An increasing rate of morbidity related to hospital-acquired infections worldwide is the major driver for the growth of hospital-acquired disease testing market. Devices employed in modern care facilities, such as catheters and ventilators are also associated with the cause of these infections.
According to World health organization (WHO), 2011, highest prevalence of hospital-acquired infections occur in intensive care units, orthopedic, and acute surgical ward. According to an article in Journal of Nursing & Health Sciences, 2016, the prevalence rate of hospital-acquired diseases is approximately 5.1% to 11.6% in emerging economies. Around 1.7 million people are affected by HAI in the U.S. itself accounting for 9.9 infections per 1000 patients a day. High prevalence rate is the key factor propelling the growth of market in near future.
Urinary tract infection is the most common infection, owing to its high risk in the patients indwelling with urinary catheter, which leads to increase chance of bacterial invasion from the anus to the urinary tract and promotes colonization of bacteria.
The most common techniques used for diagnosis of the hospital-associated infections are solid phase hybridization, PCR, and microarrays. Curetis Unyvero System, launched in 2012, a new molecular device used for rapid detection microorganism and antibiotic resistance gene. Antibiotic resistance is also the major concern factor associated with hospital-acquired Disease testing.
Key features of the study:
“*” marked represents similar segmentation in other categories in the respective section.
Table of Contents
*Browse 33 market data tables and 30 figures on "Hospital Acquired Disease Testing Market” - Global forecast to 2025”.
Coherent Market Insights followsa comprehensive research methodology focused on providing the most precise market analysis. The company leverages a data triangulation model which helps company to gauge the market dynamics and provide accurate estimates. Key components of the research methodologies followed for all our market reports include:
In addition to this, Coherent Market Insights has access to a wide range of the regional and global reputed paid data bases, which helps the company to figure out the regional and global market trends and dynamics. The company analyses the industry from the 360 Degree Perspective i.e. from the Supply Side and Demand Side which enables us to provide granular details of the entire ecosystem for each study. Finally, a Top-Down approach and Bottom-Up approach is followed to arrive at ultimate research findings.
Coherent Market Insights desk research is based on a principle set of research techniques:
Coherent Market Insights has a large amount of in-house repository of industry database. This is leveraged as a burner for initiating a new research study. Key secondary sources include:
Preliminary Data Mining
The raw data is obtained through the secondary findings, in house repositories, and trade surveys. It is then filtered to ensure that the relevant information including industry dynamics, trends, and outlook is retained for further research process.
Holistic approach is used to ensure that the granular and uncommon parameters are taken into consideration to ensure accurate results. The information from the paid databases are further combined to the raw data in order to standardize it.
Coherent Statistical model
We arrive at our final research findings through simulation models. Coherent Data Analytics Model is a statistical tool that helps company to forecast market estimates. Few of the parameters considered as a part of the statistical model include:
Once the findings are derived from the statistical model, large volume of data is process to confirm accurate research results. Data analytics and processing tools are adopted to process large chunk of collected informative data. In case, a client customizes the study during the process, the research finding till then are benchmarked, and the process for new research requirement is initiated again.
This is the most crucial stage of the research process. Primary Interviews are conducted to validate the data and analysis. This helps in achieving the following purposes:
The primary research is conducted with the ecosystem players including, but not limited to:
Finding it difficult to find the research that would cater to your business demands? Give us a chance to help you. One of our Research Consultants will connect to provide a customized solution.
Talk to our research consultant to design an exclusive report as per your research needs.
We aim to fulfil client's research demands with tailored research solutions.
We aim to provide research studies in quickest turnaround time and in a much cost effective manner.
We cover each industry from supply and demand side with an aim to provide a most holistic research study.
We strive to provide most accurate and reliable research findings in our research reports.